Company Overview
Snapshot
Founded in July 2019 by Sharon Cohen and Orit Shefi, Re:pair operates with 1–10 employees. The company graduated from the UnBox Ventures entrepreneurship program in October 2019.
Business overview
Re:pair is an Israel-based bioengineering company developing remotely activated biostructure scaffolds for tissue-engineered platforms. The company's core technology involves off-the-shelf 3D hydrogel-based artificial grafts designed to mimic natural nerve topography, facilitating rapid and accurate regeneration for long-distance nerve defects. Re:pair operates within the medical devices, tissue repair, and regenerative medicine sectors, targeting neurosurgeons, orthopedists, and plastic surgeons specializing in nerve transplantation surgeries.
Log in to access full profile ›Company Intelligence Q&A
- When was Re:pair founded and by whom?
- Re:pair was founded in July 2019 by co-founders Sharon Cohen and Orit Shefi.
- What is Re:pair's primary focus in the medical field?
- Re:pair focuses on developing hydrogel-based platforms for tissue engineering, specifically creating nerve grafts for peripheral nerve reconstruction in injuries with varied gaps.
- What kind of technology does Re:pair utilize for nerve repair?
- Re:pair develops off-the-shelf 3D hydrogel-based artificial grafts that mimic the natural topography of nerves to guide spontaneously regenerating axons for the repair of long-distance nerve defects.
- Which medical specialists are the target users for Re:pair's solutions?
- Re:pair's solutions are aimed at neurosurgeons, orthopedists, and plastic surgeons who specialize in nerve transplantation surgeries.
- Has Re:pair participated in any entrepreneurship programs?
- Yes, Re:pair graduated from the UnBox Ventures entrepreneurship program in October 2019.